PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-16.65%
Revenue decline while CRWD shows 5.94% growth. Joel Greenblatt would examine competitive position erosion.
-29.90%
Cost reduction while CRWD shows 7.31% growth. Joel Greenblatt would examine competitive advantage.
-11.75%
Gross profit decline while CRWD shows 5.45% growth. Joel Greenblatt would examine competitive position.
5.88%
Margin expansion while CRWD shows decline. John Neff would investigate competitive advantages.
6.16%
R&D growth above 1.5x CRWD's 3.75%. Michael Burry would check for spending discipline.
2.68%
G&A growth less than half of CRWD's 7.72%. David Dodd would verify if efficiency advantage is structural.
-9.25%
Marketing expense reduction while CRWD shows 1.68% growth. Joel Greenblatt would examine competitive risk.
-140.00%
Other expenses reduction while CRWD shows 0.00% growth. Joel Greenblatt would examine efficiency.
-2.37%
Operating expenses reduction while CRWD shows 3.48% growth. Joel Greenblatt would examine advantage.
-14.41%
Total costs reduction while CRWD shows 4.38% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
12.98%
D&A growth while CRWD reduces D&A. John Neff would investigate differences.
-19.84%
Both companies show EBITDA decline. Martin Whitman would check industry conditions.
-2.06%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-20.27%
Operating income decline while CRWD shows 9.37% growth. Joel Greenblatt would examine position.
-4.33%
Operating margin decline while CRWD shows 14.45% growth. Joel Greenblatt would examine position.
-104.49%
Other expenses reduction while CRWD shows 18.80% growth. Joel Greenblatt would examine advantage.
-22.77%
Pre-tax income decline while CRWD shows 20.26% growth. Joel Greenblatt would examine position.
-7.34%
Pre-tax margin decline while CRWD shows 24.73% growth. Joel Greenblatt would examine position.
-22.29%
Both companies reducing tax expense. Martin Whitman would check patterns.
-22.89%
Net income decline while CRWD shows 29.52% growth. Joel Greenblatt would examine position.
-7.48%
Net margin decline while CRWD shows 33.47% growth. Joel Greenblatt would examine position.
-22.78%
EPS decline while CRWD shows 29.55% growth. Joel Greenblatt would examine position.
-23.08%
Diluted EPS decline while CRWD shows 29.55% growth. Joel Greenblatt would examine position.
-0.01%
Share count reduction while CRWD shows 0.59% change. Joel Greenblatt would examine strategy.
0.39%
Diluted share reduction below 50% of CRWD's 0.59%. Michael Burry would check for concerns.